Ray, UpasanaJung, Deok-BeomJin, LingXiao, YinanDasari, SubramanyamBhattacharya, Sayantani SarkarThirusangu, PrabhuStaub, Julie K.Roy, DebarshiRoy, BhaskarWeroha, S. JohnHou, XiaonanPurcell, James W.Bakkum-Gamez, Jamie N.Kaufmann, Scott H.Kannan, NagarajanMitra, Anirban K.Shridhar, Viji2023-08-312023-08-312022Ray U, Jung DB, Jin L, et al. Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer. Cancer Res. 2022;82(6):1038-1054. doi:10.1158/0008-5472.CAN-21-0622https://hdl.handle.net/1805/35273Dissemination of ovarian cancer cells can lead to inoperable metastatic lesions in the bowel and omentum that cause patient death. Here we show that LRRC15, a type-I 15-leucine-rich repeat-containing membrane protein, highly overexpressed in ovarian cancer bowel metastases compared with matched primary tumors and acts as a potent promoter of omental metastasis. Complementary models of ovarian cancer demonstrated that LRRC15 expression leads to inhibition of anoikis-induced cell death and promotes adhesion and invasion through matrices that mimic omentum. Mechanistically, LRRC15 interacted with β1-integrin to stimulate activation of focal adhesion kinase (FAK) signaling. As a therapeutic proof of concept, targeting LRRC15 with the specific antibody-drug conjugate ABBV-085 in both early and late metastatic ovarian cancer cell line xenograft models prevented metastatic dissemination, and these results were corroborated in metastatic patient-derived ovarian cancer xenograft models. Furthermore, treatment of 3D-spheroid cultures of LRRC15-positive patient-derived ascites with ABBV-085 reduced cell viability. Overall, these data uncover a role for LRRC15 in promoting ovarian cancer metastasis and suggest a novel and promising therapy to target ovarian cancer metastases. Significance: This study identifies that LRRC15 activates β1-integrin/FAK signaling to promote ovarian cancer metastasis and shows that the LRRC15-targeted antibody-drug conjugate ABBV-085 suppresses ovarian cancer metastasis in preclinical models.en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalOvarian epithelial carcinomaTumor cell lineImmunoconjugatesMembrane proteinsOvarian neoplasmsArticle